Antineoplastic and immunosuppressive drugs. II. Therapeutic uses.
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002051:Burkitt Lymphoma / Q000188:drug therapy; D002277:Carcinoma / Q000188:drug therapy; D002822:Choriocarcinoma / Q000188:drug therapy; D004407:Dysgerminoma / Q000188:drug therapy; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007700:Kinetics; D007938:Leukemia / Q000188:drug therapy; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D007951:Leukemia, Myeloid / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008224:Lymphoma, Follicular / Q000188:drug therapy; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D009101:Multiple Myeloma / Q000188:drug therapy; D010051:Ovarian Neoplasms / Q000188:drug therapy; D011087:Polycythemia Vera / Q000188:drug therapy; D011247:Pregnancy; D055728:Primary Myelofibrosis / Q000188:drug therapy; D009396:Wilms Tumor / Q000188:drug therapy
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents